期刊文献+

胃癌患者外周血miR-183水平的临床意义 被引量:4

Level of miR-183 in peripheral blood of the patients with gastric cancer
下载PDF
导出
摘要 目的·研究胃癌患者外周血mi R-183水平在胃癌的诊断及预后判断中的价值。方法·实时定量PCR(q RT-PCR)法检测76例胃癌患者及同期26例正常对照者外周血清mi R-183的水平,分析mi R-183水平与胃癌患者临床病理特征及预后的关系。结果·胃癌患者血清中mi R-183水平明显高于正常对照者(4.798±0.267 vs 0.904±0.067,P=0.000)。mi R-183水平与患者年龄、性别、肿瘤分化程度无明显相关性(P>0.05);与肿瘤浸润深度、有无淋巴结转移或远处转移及TNM分期有关(P<0.05)。受试者工作特征曲线分析结果显示,mi R-183在预测胃癌发生时,ROC曲线下面积(AUC)为0.978(95%CI为0.955~1.001),敏感度为93.42%,特异度为92.31%;在预测胃癌转移(淋巴结转移或远处转移)时,其AUC值为0.643(95%CI为0.507~0.780),敏感度为67.31%,特异度为58.33%。结论·mi R-183在血清中的水平上调与胃癌发生、发展有关,胃癌患者血清中的表达上调与胃癌的临床病理特征及患者预后密切相关,mi R-183可能成为胃癌诊断及预后判断的分子标志。 Objective·To evaluate level of miR-183in peripheral blood of the patients with gastric cancer for diagnosis and prognosis.Methods·Quantitative real-time PCR was used to detect the miR-183levels in sera of76cases of gastric cancer patients and26cases of normal controlat the same term.The correlations of miR-183levels with clinicopathological features and clinical prognosis were analyzed.Results·The significantlyhigher levels of miR-183were observed in the sera of gastric cancer patients(4.798±0.267vs0.904±0.067,P=0.000)as compared with those in thecorresponding control group.Up-regulation of miR-183was associated with invasion depth,positive lymph node or distant metastasis,and advancedclinical stage in gastric cancer patients(P<0.05),but not associated with age,sex,and degree of tumor differentiation(P>0.05).ROC curve analysisshowed that the AUC value of miR-183in the prediction of gastric cancer was0.978(95%CI0.955-1.001)with sensitivity of93.42%and specificity of92.31%.In the prediction of metastasis(lymph node metastasis or distant metastasis),the AUC value was0.643(95%CI0.507-0.780)with sensitivity of67.31%and specificity of58.33%.Conclusion·The high level of miR-183in serum is associated with gastric cancer development,its clinicopathologicalfeatures and patient’s clinical prognosis.It may be used as a potential diagnostic bio-marker and a prognostic predictor in the patients with gastric cancer.
作者 孙颖 马瑾 胡梅洁 郑雄 李健 顾玮 SUN Ying;MA Jin;HU Mei-jie;ZHENG Xiong;LI Jian;GU Wei(Department of Gastroenterology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai 200020, China;Department of Gastroenterology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China)
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2017年第1期75-79,共5页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市黄浦区科研项目(HKW201303)~~
关键词 微小RNA miR-183 胃癌 TNM分期 microRNA miR-183 gastric cancer TNM stage
  • 相关文献

参考文献2

二级参考文献20

  • 1Duffy MJ. Clinical uses of tumor markers: a critical review. Crit Rev Clin Lab Sci 2001; 38:225-262.
  • 2Thomas CM, Sweep CG. Serum tumor markers: past, state of the art, and future, lnt J Biol Markers 2001; 16:73-86.
  • 3Duffy MJ. Role of tumor markers in patients with solid cancers: a critical review. Eur J lntern Med 2007; 18:175-184.
  • 4Roulston JE. Limitations of tumour markers in screening. Br J Surg 1990; 77:961-962.
  • 5Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259-269.
  • 6Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6:857-866.
  • 7Chen C, Ridzon DA, Broomer A J, et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005; 33:e179.
  • 8Tang F, Hajkova P, Barton SC, Lao K, Surani MA. MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res 2006; 34:e9.
  • 9Hafner M, Landgraf P, Ludwig J, et al. Identification of microRNAs and other small regulatory RNAs using cDNA library sequencing. Methods 2008; 44:3-12.
  • 10Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103:2257-2261.

共引文献1056

同被引文献55

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部